NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
USA - NYSE:NUS - US67018T1051 - Common Stock
11.75 USD
-0.08 (-0.68%)
Overall NUS gets a fundamental rating of 5 out of 10. We evaluated NUS against 36 industry peers in the Personal Care Products industry. While NUS has a great health rating, its profitability is only average at the moment. NUS has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
NUS had positive earnings in the past year.
NUS had a positive operating cash flow in the past year.
Of the past 5 years NUS 4 years were profitable.
In the past 5 years NUS always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 6.98%, NUS is doing good in the industry, outperforming 69.44% of the companies in the same industry.
NUS has a better Return On Equity (12.80%) than 77.78% of its industry peers.
With a Return On Invested Capital value of 3.88%, NUS perfoms like the industry average, outperforming 52.78% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for NUS is significantly below the industry average of 12.97%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| ROIC | 3.88% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
Looking at the Profit Margin, with a value of 6.20%, NUS is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
With a Operating Margin value of 3.51%, NUS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
NUS's Operating Margin has declined in the last couple of years.
NUS has a Gross Margin of 67.23%. This is comparable to the rest of the industry: NUS outperforms 55.56% of its industry peers.
In the last couple of years the Gross Margin of NUS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.51% | ||
| PM (TTM) | 6.2% | ||
| GM | 67.23% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
NUS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NUS has more shares outstanding
The number of shares outstanding for NUS has been reduced compared to 5 years ago.
Compared to 1 year ago, NUS has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.81 indicates that NUS is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.81, NUS is doing good in the industry, outperforming 61.11% of the companies in the same industry.
The Debt to FCF ratio of NUS is 0.61, which is an excellent value as it means it would take NUS, only 0.61 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.61, NUS belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
A Debt/Equity ratio of 0.27 indicates that NUS is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.27, NUS perfoms like the industry average, outperforming 52.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 0.61 | ||
| Altman-Z | 3.81 |
ROIC/WACC0.51
WACC7.56%
2.3 Liquidity
A Current Ratio of 2.01 indicates that NUS has no problem at all paying its short term obligations.
NUS has a Current ratio of 2.01. This is comparable to the rest of the industry: NUS outperforms 55.56% of its industry peers.
A Quick Ratio of 1.38 indicates that NUS should not have too much problems paying its short term obligations.
NUS's Quick ratio of 1.38 is fine compared to the rest of the industry. NUS outperforms 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
NUS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.63%.
Measured over the past years, NUS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.85% on average per year.
NUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.80%.
NUS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.47% yearly.
EPS 1Y (TTM)-1.63%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%104.76%
Revenue 1Y (TTM)-11.8%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-12.06%
3.2 Future
Based on estimates for the next years, NUS will show a very strong growth in Earnings Per Share. The EPS will grow by 36.15% on average per year.
NUS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.71% yearly.
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 9.71 indicates a reasonable valuation of NUS.
Compared to the rest of the industry, the Price/Earnings ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 91.67% of the companies listed in the same industry.
NUS is valuated cheaply when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
NUS is valuated cheaply with a Price/Forward Earnings ratio of 7.46.
Based on the Price/Forward Earnings ratio, NUS is valued cheaper than 94.44% of the companies in the same industry.
NUS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.77, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.71 | ||
| Fwd PE | 7.46 |
4.2 Price Multiples
91.67% of the companies in the same industry are more expensive than NUS, based on the Enterprise Value to EBITDA ratio.
NUS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NUS is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.42 | ||
| EV/EBITDA | 4.81 |
4.3 Compensation for Growth
NUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NUS's earnings are expected to grow with 36.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y36.15%
EPS Next 3YN/A
5. Dividend
5.1 Amount
NUS has a Yearly Dividend Yield of 2.05%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.51, NUS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, NUS has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.05% |
5.2 History
The dividend of NUS decreases each year by -30.50%.
NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
11.83% of the earnings are spent on dividend by NUS. This is a low number and sustainable payout ratio.
DP11.83%
EPS Next 2Y36.15%
EPS Next 3YN/A
NYSE:NUS (9/16/2025, 2:23:46 PM)
11.75
-0.08 (-0.68%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners75.35%
Inst Owner Change-2.56%
Ins Owners2.16%
Ins Owner Change3.24%
Market Cap581.63M
Analysts45
Price Target7.65 (-34.89%)
Short Float %3.99%
Short Ratio3.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.05% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP11.83%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.8%
Min EPS beat(2)73.77%
Max EPS beat(2)73.83%
EPS beat(4)3
Avg EPS beat(4)52.6%
Min EPS beat(4)-13.83%
Max EPS beat(4)76.64%
EPS beat(8)6
Avg EPS beat(8)40.86%
EPS beat(12)9
Avg EPS beat(12)30.24%
EPS beat(16)13
Avg EPS beat(16)24.81%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.5%
Max Revenue beat(2)2.51%
Revenue beat(4)3
Avg Revenue beat(4)0.44%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.53%
Revenue beat(12)5
Avg Revenue beat(12)-1.53%
Revenue beat(16)7
Avg Revenue beat(16)-1.15%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)4.9%
EPS NQ rev (3m)4.9%
EPS NY rev (1m)27.02%
EPS NY rev (3m)27.02%
Revenue NQ rev (1m)-3.58%
Revenue NQ rev (3m)-3.58%
Revenue NY rev (1m)2.27%
Revenue NY rev (3m)2.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.71 | ||
| Fwd PE | 7.46 | ||
| P/S | 0.36 | ||
| P/FCF | 1.42 | ||
| P/OCF | 1.3 | ||
| P/B | 0.74 | ||
| P/tB | 0.88 | ||
| EV/EBITDA | 4.81 |
EPS(TTM)1.21
EY10.3%
EPS(NY)1.58
Fwd EY13.41%
FCF(TTM)8.3
FCFY70.65%
OCF(TTM)9
OCFY76.63%
SpS32.86
BVpS15.91
TBVpS13.3
PEG (NY)0.2
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| ROCE | 4.92% | ||
| ROIC | 3.88% | ||
| ROICexc | 5.04% | ||
| ROICexgc | 5.89% | ||
| OM | 3.51% | ||
| PM (TTM) | 6.2% | ||
| GM | 67.23% | ||
| FCFM | 25.27% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexcg growth 3Y-45.58%
ROICexcg growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 0.61 | ||
| Debt/EBITDA | 1.81 | ||
| Cap/Depr | 56.99% | ||
| Cap/Sales | 2.14% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 377.59% | ||
| Profit Quality | 407.56% | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 3.81 |
F-Score6
WACC7.56%
ROIC/WACC0.51
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.63%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%104.76%
EPS Next Y49.72%
EPS Next 2Y36.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.8%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-12.06%
Revenue Next Year-11.95%
Revenue Next 2Y-5.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.66%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21528.6%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y561.31%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%